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Combined preparations containing as a principal component 
urea (generic name carbamide) with a chemotherapeutic drug, re-
spectively a pharmacological agent, are still in an initial research 
phase. In historical aspect , to the best of our knowledge from the lit-
erature available there is no data about a preparation containing a 
combination of urea and antibiotics including aminoglycosides ( 1 -
3,5). Under sale is only Nifucin-gel (Germany) , a combination of urea 
5% and nitrofurazon 0 . 2 % (5) . According to our pharmacological and 
microbiological investigations, MIC of Gentamicin (128 jxg/ml) de-
c reases almost thrice in 31 out of 33 strains of Klebsiel la, Proteus, 
Citrobacter and E. col i . S o we proposed a gentamicin 0 . 1 % - urea 
0 . 2 % combination to be prepared for further research in ointment 
form (4 ,6 -7 ) . The aim of this work is : 1) to compare its cl inical anti-
bacterial effects as judged by the isolated bacterial strains before 
and during the treatment with our previous data from in vitro studies; 
and 2) to col lect an information on the tolerability, i.e. on possible 
side effects. We studied 10 patients aged 6 -83 years with skin burns 
of l l l -A degree, 5 of which were outpatients (table 1). 
The ointment w a s spread in a thin (1 -2 mm) layer and covered 
by a sterile bandage renewed every 48h. (4 ,7) . The microbial flora 
was isolated before and after the 4 8 t h h and the 96 h from the be-
ginning of the treatment with the ointment mentioned above, in 9 0 % 
of the patients treated the initially isolated bacteria were not found 
after the first 4 therapeutic days . The flora detected included: 3 pa-
tients with Staph, aureus, 2 with E. col i , 4 with Proteus and 1 with E n -
terobacter. In one patient only there was no sterile result on the 9 6 t h 
h. These results are in good agreement with our previous in vitro 
data, according to which this combination reduces Gentamicin MIC 
values by 3 0 0 % in 8 strains of Proteus and by 2 1 8 % in 11 strains of 
E.coli (4 ,6 ,7) . As for the tolerability of the ointment form of this c o m -
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bination, no side effects were cl inically registered. 
Table 1 / 
Isolated bacteria before and during the treatment with the c o m ­
bination of Gentamycin 0 .1%-Urea 0 . 2 % in ointment form 
initials, Area I f c ^ T ^ n g ^ R e ^ 
age and of skin before д л ™ . _ t QRxh . °f 
sex treated treat- a t 4 8 h a t 9 6 h d isease 
ment after treatment 
1. E M Y 6 8 f Hands, Proteus Proteus Staph. 6959 
L / R foot aureus 
2. D S G 83 f Gluteal, Proteus Proteus None 6822 
thighs 
3. T D G 7 6 m Feet Proteus Staph None 7041 
aureus 
4. T A J 7 7 m Feet Staph. Staph. None 6642 
aureus aureus 
5.IGP 31 m Face, Staph. Proteus None 6874 
forearm aureus 
6. D D I 32 f Feet Entero- Entero- None ambula-
bacter bacter tory 
7. Z G Z 43 m Feet Proteus Staph. None ambula-
aureus tory 
8 .0JM 6 m Forethighs, Staph. Staph. None ambula-
thighs aureus aureus tory 
9. A I G 39 f Hands E.coli Staph. None ambula-
aureus tory . 
10. V I D 28 f Thighs E.coli Staph. None ambula-
aureus tory 
R E F E R E N C E S : LMar ler E. Pharmacologica l and chemica l sy ­
nonyms. Amsterdam, Excerpta Medica, 1983. 2 .Phys ic ian 's desk ref­
e r e n c e s . 4 4 . e d . W a s h i n g t o n , 1 9 9 0 . 3 . R o t e L i s t e 1 9 9 0 . 
Frankfurt/M,1990. 4.Temnyalov N., et a l . Abstr. VII Natl. Conf. Phar ­
macol . C l in . Bulgar. Drugs. Sof ia , 1988. 5 .Vademecum. Drugs of DDR 
registered in Bulgaria. Sof ia , 1984. 6.Zhelyazkov D., N.Temnyalov, 
R.Marinova. A technical report, Razgrad,1984. 7 .Zhe lyazkovD. , et a l . 
A t e c h i n i c a l report. State Reg . No 83826,Sof ia ,20.04.1988. 
